2020
DOI: 10.1126/sciadv.aaz6579
|View full text |Cite
|
Sign up to set email alerts
|

Cellular backpacks for macrophage immunotherapy

Abstract: Adoptive cell transfers have emerged as a disruptive approach to treat disease in a manner that is more specific than using small-molecule drugs; however, unlike traditional drugs, cells are living entities that can alter their function in response to environmental cues. In the present study, we report an engineered particle referred to as a “backpack” that can robustly adhere to macrophage surfaces and regulate cellular phenotypes in vivo. Backpacks evade phagocytosis for several days and release cytokines to… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

5
228
1

Year Published

2020
2020
2021
2021

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 285 publications
(234 citation statements)
references
References 60 publications
5
228
1
Order By: Relevance
“…In their recent study, Shields et al successfully employed a particle-based technology of macrophage transfer to induce the pro-inflammatory immune response [ 69 ]. Macrophages carrying the “IFN-γ backpacks” showed their efficacy against murine mammary carcinoma by conferring stable M1 polarization of TAMs.…”
Section: The Existing Approaches For Macrophage Reprogrammingmentioning
confidence: 99%
“…In their recent study, Shields et al successfully employed a particle-based technology of macrophage transfer to induce the pro-inflammatory immune response [ 69 ]. Macrophages carrying the “IFN-γ backpacks” showed their efficacy against murine mammary carcinoma by conferring stable M1 polarization of TAMs.…”
Section: The Existing Approaches For Macrophage Reprogrammingmentioning
confidence: 99%
“…Recently, Michael Klichinsky et al described an anti-HER2 CAR-macrophage (CAR-M) that significantly reduced metastatic tumor burden (131). A cellular IFN-γ "backpack" for macrophages was reported to promote phagocytosis and polarize macrophages toward the M1 phenotype, which further slows down the tumor growth in a murine breast cancer model (132). Overall, the adoptive transfer therapy of macrophages is still in the research stage, and there are many problems to be solved, such as the establishment of pre-clinical models to evaluate the efficacy and safety of AMT.…”
Section: Adoptive Macrophages Transfermentioning
confidence: 99%
“…Recently, Shields et al. [ 152 ] proposed the cellular backpack strategy to attach an engineered particle to macrophage surfaces for regulation of cellular phenotypes in vivo . Well-considered nanoarchitectonics modification of the cell surface leads to living cell systems with responding capabilities to designed external stimuli.…”
Section: Perspectivementioning
confidence: 99%